New Zealand markets closed

MicroTech Medical (Hangzhou) Co., Ltd. (2235.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
3.900+0.050 (+1.30%)
As of 03:35PM HKT. Market open.

MicroTech Medical (Hangzhou) Co., Ltd.

No. 108 Liuze Street
Cangqian Street Yuhang District
86 40 0083 1811

IndustryMedical Devices
Full-time employees760

Key executives

NameTitlePayExercisedYear born
Dr. Pan ZhengExecutive Chairman & CEO1.16MN/A1971
Ms. Xiu LiuExecutive Director, Financial Controller & Secretary of the Board780.61kN/A1980
Dr. Fei YuExecutive Director and Director of R&D Department1.04MN/A1982
Dr. Yonghui ShiSVP, Chief Strategy & Development Officer, Joint Company Secretary and Executive Director1.4MN/A1981
Ms. Fangling XuVP & Head of Administration Department98.95kN/A1984
Mr. Duo BoLegal OfficerN/AN/A1992
Mr. Yi LanVice President of MarketingN/AN/A1971
Ms. Pik Man ChuJoint Company SecretaryN/AN/A1997
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.


MicroTech Medical (Hangzhou) Co., Ltd. engages in the research and development, manufacture, and sale of medical devices for diabetes monitoring, treatment, and management in the People's Republic of China and internationally. The company offers Equil patch insulin pump systems; AiDEX and LinX continuous glucose monitoring systems; POCT analyzer systems; closed-loop artificial pancreas systems; blood glucose monitoring systems; Exactive Pro blood glucose, blood ketone, and uric acid monitoring system; and diabetes digital management software. It is also involved in scientific research and technical services; business services; wholesale and retail; manufacturing; and commercials. MicroTech Medical (Hangzhou) Co., Ltd. was incorporated in 2011 and is headquartered in Hangzhou, the People's Republic of China.

Corporate governance

MicroTech Medical (Hangzhou) Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.